Login Register Cart 0
Generic placeholder image

Current Nanomedicine

Editor-in-Chief

ISSN (Print): 2468-1873
ISSN (Online): 2468-1881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

COVID-19: Structure, Replication and its Global Scenario

Author(s): Swati Chauhan*

Volume 11, Issue 1, 2021

Published on: 05 October, 2020

Page: [16 - 20] Pages: 5

DOI: 10.2174/2468187310999201005213149

Price: $65

Abstract

Background: The disease leading the whole world in a lockdown state, Coronavirus, is a highly transmitted virus that has spread to the whole world with an intensive speed.

Introduction: Novel coronavirus, termed as COVID-19, is an RNA genome comprising spherical spiked structure, which can infect humans by majorly attacking the respiratory system. The infection is characterized by high fever, dry cough and fatigue. The purpose of this review is to highlight the main characteristic features of COVID-19, the symptoms, and the genetic material present in the virus. The review also focuses on the uniqueness of this virus from other viruses, which has made it difficult to develop a vaccine for its cure.

Discussion and Conclusion: The review has illustrated the number of people who have been affected by COVID 19 in the world with a special emphasis on India. Analysis has shown that how vastly COVID- 19 has affected human beings.

Keywords: Pandemic, Structure, RNA, Replication, Global scenario, COVID 19.

« Previous Next »
Graphical Abstract

[1]
Cascella M, Rajnik M, Cuomo A, et al. Features, Evaluation and Treatment Coronavirus (COVID-19) StatPearls Publishing . 2020.
[2]
Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med 2020; 172(9): 577-82.
[http://dx.doi.org/10.7326/M20-0504] [PMID: 32150748]
[3]
Raoult D, Zumla A, Locatelli F, et al. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses Cell Stress. 2020.
[4]
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 2020; 10(2): 102-8.
[http://dx.doi.org/10.1016/j.jpha.2020.03.001] [PMID: 32282863]
[5]
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015; 1282: 1-23.
[http://dx.doi.org/10.1007/978-1-4939-2438-7_1] [PMID: 25720466]
[6]
Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020; 7(1): 11.
[http://dx.doi.org/10.1186/s40779-020-00240-0] [PMID: 32169119]
[7]
Kim JM, Chung YS, Jo HJ, et al. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. Osong Public Health Res Perspect 2020; 11(1): 3-7.
[http://dx.doi.org/10.24171/j.phrp.2020.11.1.02] [PMID: 32149036]
[8]
Jeong YS, Makino S. Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effects of subgenomic RNA transcription on RNA replication. J Virol 1992; 66(6): 3339-46.
[http://dx.doi.org/10.1128/JVI.66.6.3339-3346.1992] [PMID: 1583719]
[9]
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020; 24: 91-8.
[http://dx.doi.org/10.1016/j.jare.2020.03.005] [PMID: 32257431]
[10]
Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
[11]
Ministry of Health and Family Welfare, Government of India. https://www.mohfw.gov.in/
[12]
COVID-19 Information & Updates. https://covid19.org.in/covid19oinformation/
[13]
WHO Coronavirus (COVID-19) Dashboard. https://covid19. who.int/

Rights & Permissions Print Cite
Article Metrics
19
© 2024 Bentham Science Publishers | Privacy Policy